From: Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine
Local reactions
Any
6/29 (21%)
Tenderness
4/29 (14%)
Erythema
2/29 (7%)
Systemic reactions
5/29 (17%)
Headache
1/29 (3%)
Nausea/dizziness
Hypertension
Nasal congestion/raised temperature
Hay fever